BLOC1S2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.92879087438314E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.88030000142825E-08 |
Normal-vs-Stage2 |
1.596220E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.277540E-03 |
Stage1-vs-Stage2 |
7.631800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.643800E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.050000E-02 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.08349995642243E-09 |
Normal-vs-AfricanAmerican |
1.420580E-01 |
Normal-vs-Asian |
3.574000E-02 |
Caucasian-vs-AfricanAmerican |
4.571600E-01 |
Caucasian-vs-Asian |
5.161000E-01 |
AfricanAmerican-vs-Asian |
8.086400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.03749999999614E-05 |
Normal-vs-Female |
1.22170000005362E-07 |
Male-vs-Female |
4.449600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.161600E-03 |
Normal-vs-Extreme_Weight |
6.9104000000042E-07 |
Normal-vs-Obese |
5.961700E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.793200E-01 |
Normal_Weight-vs-Obese |
2.026400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.854200E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.688400E-01 |
Normal-vs-Age(41-60Yrs) |
1.007260E-04 |
Normal-vs-Age(61-80Yrs) |
2.12380000030876E-07 |
Normal-vs-Age(81-100Yrs) |
1.773380E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.760600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.077600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.196800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.823400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.625000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.924400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.522000E-01 |
Normal-vs-Grade 3 |
3.360600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.801600E-01 |
Grade 2-vs-Grade 4 |
3.522000E-01 |
Grade 3-vs-Grade 4 |
3.360600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.03309974095612E-10 |
Normal-vs-N1 |
1.721520E-02 |
N0-vs-N1 |
2.535800E-02 |
|
|